ArticleCardiology and therapy2021

Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19).

Mihály Medvegy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.